6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge

Location: Federal
Posted: Dec 16, 2025
Due: Mar 16, 2026
Agency: VETERANS AFFAIRS, DEPARTMENT OF
Type of Government: Federal
Category:
  • 65 - Medical, Dental, and Veterinary Equipment and Supplies
Solicitation No: 36C77026Q0061
Publication URL: To access bid details, please log in.
Follow
6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge
Active
Contract Opportunity
Notice ID
36C77026Q0061
Related Notice
Department/Ind. Agency
VETERANS AFFAIRS, DEPARTMENT OF
Sub-tier
VETERANS AFFAIRS, DEPARTMENT OF
Office
NATIONAL CMOP OFFICE (36C770)
Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information
  • Contract Opportunity Type: Sources Sought (Original)
  • Original Published Date: Dec 16, 2025 08:28 am CST
  • Original Response Date: Mar 16, 2026 09:00 am CDT
  • Inactive Policy: Manual
  • Original Inactive Date: Jun 14, 2026
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: 6505 - DRUGS AND BIOLOGICALS
  • NAICS Code:
    • 325412 - Pharmaceutical Preparation Manufacturing
  • Place of Performance:
    Department of Veterans Affairs Multiple Locations ,
Description
36C77026Q0061
Request for Information (RFI):
Domestic Pharmaceutical Manufacturing 36C77026Q0061
1. Overview
The Department of Veterans Affairs (VA), Consolidated Mail Outpatient Pharmacy (CMOP) operates seven sites across the United States, supporting the daily mailout of approximately 450,000 prescriptions to Veterans. While the majority of these prescriptions are fulfilled through the Prime Vendor contract, CMOP supplements its supply through Open Market (OM) purchases when necessary, through solicitations that get published to the System for Award Management (SAM) website, similar to how this RFI is being published.

To support these OM requirements, the Government has an ongoing need to identify pharmaceutical end items manufactured, processed, or produced by domestic small and large businesses. This RFI is issued solely for market research and procurement planning purposes and does not constitute a Request for Quote (RFQ) or Request for Proposal (RFP). This notice shall not be construed as a commitment by the Government to ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. This request does not constitute a solicitation for proposals or quotes or the authority to enter into negotiations to award a contract. No funds have been authorized, appropriated, or received for this effort. Related details can be found in section six (6) regarding the nature of this RFI.
2. Purpose
The purpose of this RFI is to:
Identify domestic small and large business pharmaceutical manufacturers with efficient production capabilities related to FAR Part 12 Acquisition of Commercial Products and Commercials Services in combination with FAR Part 25 Foreign Acquisition procedures.
Gather information on manufacturers of pharmaceuticals and ancillary items related to CMOP s OM purchases.
Promote early exchanges of information in accordance with Federal Acquisition Regulation (FAR) Overhaul Part 15.101, to improve mutual understanding of Government needs and industry capabilities.
Deeper Insight into Small Business type considerations in manufacturing to include all socio-economic considerations with the highest interest in Service-Disabled Veteran Owned Small Businesses (SDVOSB) and Veteran Owned Small Business (VOSB) Manufacturers.
3. Scope
The overall intent of the RFI is to provide outreach within the designated NAICS codes:
325412 - Pharmaceutical Preparation Manufacturing
325413 - In-Vitro Diagnostic Substance Manufacturing
The list presented below is not exhaustive of pharmaceutical and medical surgical items that may be required in Fiscal Year (FY) 26 and is subject to be updated periodically as our requirements change.
CMOP is seeking information from both small and large domestic manufacturers capable of providing the following items to support CMOP s OM needs:
Station item #
Pharmaceutical Description
Treatment
16822
ABALOPARATIDE 80MCG/O.04ML PEN 156ML
Used for those who suffer from high risk osteoporosis
10834
ACAMPROSATE CA 333MG TAB
Used to help overcome alcoholism
18491
ARMODAFINIL 250MGTAB
Used to treat excessive sleepiness (narcolepsy)
12784
ARMODAFINIL 50MG TAB
Used to treat excessive sleepiness (narcolepsy)
2955
ARTIFICIAL SALIVA ORAL SPRAY
Used to treat dry mouth or bad breath
13125
BREAST MILK, STORAGE BAGS, 100ct
Used to store breast milk
15663
BRIMONIDINE TARTRATE 0.025% OPH SOLN
Used to lower pressure inside the eye
12679
CALCIUM 500MG/VITAMIN D 500UNIT CHEW TAB
Used to treat low calcium and vitamin D levels
13707
CARBOXYMETHYLCELLULOSE NA 0.25% OPH SOLN 15ML
Used to treat dry eyes
XV066
CATH SET, INTERMIT 14FR H#96144
Used to drain the bladder
XT265
CATH,EXTERNAL EXTENDED WEAR MED H#9207
Used to drain the bladder
C0820
CLINDAMYCIN P04 1% TOP SWAB
Used to treat acne lesions
C0482
CLOMIPHENE CITRATE 50MG TAB
Used to induce ovulation (egg production)
C0731
COAL TAR 2% SHAMPOO
Used to treat eczema, psoriasis, dermatitis, and other skin disorders
C0609
COLESTIPOL HCL 1GM TAB
Used to lower high cholesterol levels in the blood
D0025
DESONIDE 0.05% CREAM,TOP
Used to relieve redness, itching and other discomfort caused by skin conditions
D0938
DORZOLAMIDE 22.3/TIMOLOL6.8MG/ML PF OPH
used to treat increased pressure in the eye
D0828
DORZOLAMIDE 22.3_TIMOLOL6.8MG_ML OPH SOL
Used to treat increased pressure in the eye
XH825
DRESSING,DRAWTEX 4IN X 4IN
Treatment in wound care
D1217
DROSPIRENONE 4MG TAB,28
Used to prevent ovulation and pregnancy
D0922
DULOXETINE HCL 20MG EC CAP
Used to treat depression and anxiety
D0929
DULOXETINE HCL 30MG EC CAP
Used to treat depression and anxiety
D0924
DULOXETINE HCL 60MG EC CAP
Used to treat depression and anxiety
XJ196
ELECTRODE PAD EARCLIP AS#EEP
Used with an electrotherapy stimulator for the treat anxiety, depression, and insomnia
E0811
ESOMEPRAZOLE 20MG (BASE) EC CAP
Used for the treatment of erosive esophagitis
E0301
EYELID CLEANSER,EYE SCRUB PAD
Used to maintain ocular surface health for patients with blepharitis, MGD, and demodex infections
XK812
FEMALE CONDOM,INTERNAL
Used to help prevent pregnancy and reduce the risk of sexually transmitted diseases
F0355
FENOFIBRATE 145MG TAB
Used to reduce elevated low-density lipoprotein cholesterol
F0354
FENOFIBRATE 48MG TAB
Used to reduce elevated low-density lipoprotein cholesterol
F0423
FESOTERODINE FUMARATE 4MG SA TAB
Used for the treatment of overactive bladder
F0135
FOSINOPRIL NA 40MG TAB 90CT
Used for the treatment of hypertension
G0257
GALANTAMINE HYDROBROMIDE 8MG SA CAP
Treatment of mild to moderate dementia of the Alzheimer's
G0194
GLIPIZIDE 2.5MG SA TAB
Used to improve glycemic control in adults with diabetes
H0066
HYDROCORTISONE ACETATE 25MG RTL SUPP
Used to treat hemorrhoids
I0004
IBUPROFEN 400MG TAB
Used to treat pain, fever, and inflammation
I0005
IBUPROFEN 600MG TAB
Used to treat pain, fever, and inflammation
I0006
IBUPROFEN 800MG TAB
Used to treat pain, fever, and inflammation
J0040
JASMIEL TAB,28
Used to prevent pregnancy
L0329
LANSOPRAZOLE 15MG SA DISINTEGRATING TAB
Treatment of ulcers
L0330
LANSOPRAZOLE 30MG SA DISINTEGRATING TAB
Treatment of ulcers
XZ156
LEG BAG COMBINATION PK H#9349 LATEX FREE
Used to collect urine through a catheter drain tube
L0780
LEVODOPA 42MG INHL CAP
Used in the treatment of Parkinson disease as a dopamine replacement

LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB
used to treat different types of bacterial infections.
M1295
METFORMIN (EQV-FORTAMET) 1000MG SA TAB
Management of type 2 diabetes
M0103
MINOCYCLINE HCL 50MG CAP
Used to treat infections cased by bacteria
N0567
NEBIVOLOL 5MG TAB
Used to treat high blood pressure
XZ173
ONE TOUCH ULTRA (GLUCOSE) TEST STRIPS 50CT & 100CT
Used to test blood glucose levels in managing type 1 & 2 diabetes
XH026
PAD,NURSING DISPOSABLE
Used on breast feeding mothers to absorb any milk that may leak between feedings
P0535
PIOGLITAZONE HCL 15MG TAB
Management of type 2 diabetes
P0536
PIOGLITAZONE HCL 30MG TAB
Management of type 2 diabetes
P0537
PIOGLITAZONE HCL 45MG TAB
Management of type 2 diabetes
P0110
PREDNISONE 1MG TAB 1000CT
Corticosteriod used on the immune system to help relieve swelling, redness, itching, and allergic reactions
P0156
PROPRANOLOL HCL 60MG SA CAP - 33030
used to treat high blood pressure
P0175
PYRIDOSTIGMINE BROMIDE 60MG TAB
Used to treat myasthenia gravis muscle weakness
R0233
RESOURCE BENEPROTEIN PWDR,227GM
used to supply protein needed to help maintain muscle. For patients that can t eat food.
XJ330
SET,INFUSION AUTOSOFT XC TANDEM #1001680
Used to manage diabetes by delivering insulin from a pump to the body
XJ441
SET,INFUSION AUTOSOFT XC TANDEM #1001729
Used to manage diabetes by delivering insulin from a pump to the body
S0578
SEVELAMER CARBONATE 800MG TAB
For the control of serum phosphorus in adults with chronic kidney disease on dialysis
S0167
SODIUM CHLORIDE 2% OPH SOLN
Used to reduce surface corneal swelling of the eye
S0174
SUMATRIPTAN 6MG_0.5ML INJ SYRINGE 0.5ML
Used for treatment of migraines
U0004
UREA 40% CREAM
Used to treat dry/rough skin conditions and some nail problems
Z0005
ZINC OXIDE 20% OINT (60GM & 464GM)
Used to treat or prevet skin irritation
Z0067
ZOLPIDEM TARTRATE 12.5MG SA TAB
Used to treat insomnia
4. Submission Guidelines
If your company manufactures pharmaceuticals that are not listed above and are produced domestically in accordance with (IAW) FAR Part 25.001(c), please provide the following information:
Company Information:
Name, physical address, and point of contact
Physical address of domestic manufacturing facility
Socioeconomic status (e.g., SDVOSB, VOSB, 8(a), etc.) to include both large and small business types
Business size and SAM UEI Number

Product Information:
List of domestically manufactured pharmaceuticals
FDA-approved NDC numbers
Treatment usage of each pharmaceutical
Authorized distributors
Average cost for common prescription quantities
Operational Capability:
Manufacturing facility production capacity (volume)
Frequency of stockouts in the past 12 months
Typical replenishment timelines
Commercial entities where the items have been sold to for ultimate large volume dispensing.
Contracting Information:
GSA/FSS/NAC contract numbers (if applicable)
Suggested alternative NAICS or PSC codes, if more appropriate
Compliance:
Any manufacturer responding to this announcement must be able to show their capability to comply with:
Ability to meet federal, state, and local regulations
Capacity to support all seven CMOP sites if needed
Interested manufacturers are reminded that in accordance with FAR 4.12, prospective contractors shall complete electronic annual representations and certifications in conjunction with FAR 4.11 required registration in the System for Award Management (SAM) database prior to award of a contract.
5. Response Instructions:
If you believe you are capable of meeting the requirement, please provide a complete capability statement and response by March 15, 2026, at 4:30 pm CT to:
Michael McAlhaney
Email: michael.mcalhaney@va.gov
Tresanna Tacia
Email: tresanna.tacia@va.gov

Subject Line of Email: Must start with the 1) RFI Number 36C77026Q0061 followed by the 2) generic pharmaceutical name. The proprietary name should only be used when there are no FDA approved generic options.

Use the Excel Spreadsheet inputs as identified as Manufacturer Inputs_Excel as part of a complete submission.
6. Important Notice
PLEASE NOTE: This RFI is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. Respondents are solely responsible for all expenses associated with responding to this RFI. The Government does not intend to award a contract on the basis of the RFI or otherwise pay for the information requested. Responses will be treated as information only and not as a proposal.
Attachments/Links
Contact Information
Contracting Office Address
  • 5049 SOUTH 13TH STREET
  • LEAVENWORTH , KS 66048
  • USA
Primary Point of Contact
Secondary Point of Contact


History
  • Dec 16, 2025 08:28 am CSTSources Sought (Original)

Related Document

Mar 16, 2026[Special Notice (Original)] 6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge Amendment 0001
Daily notification on new contract opportunities

With GovernmentContracts, you can:

  • Find more opportunities and win more business
  • Receive daily alerts for all new bid opportunities
  • Get contract opportunities matched to your business
ONE WEEK FREE TRIAL

See also

...Follow MARKER,PEN Active Contract Opportunity Notice ID N0010425QBL10 Related Notice Department...

DEPT OF DEFENSE

Bid Due: 6/22/2026

...of Performance: Description The US Fish and Wildlife is seeking to purchase Fish ...

INTERIOR, DEPARTMENT OF THE

Bid Due: 6/11/2026

* Disclaimer: Information regarding bids, requests for proposals (RFPs), or requests for qualifications (RFQs) is provided on this website only for convenience and does not constitute official public notice. Persons wishing to respond to or inquire about bids, RFPs, or RFQs should contact the appropriate government department.